Melrose Industries Plc Price Target Increased to GBX 330 by Analysts at Investec (MRO)
Equities research analysts at Investec upped their price objective on shares of Melrose Industries Plc (LON:MRO) from GBX 325 ($5.38) to GBX 330 ($5.46) in a research note issued to investors on Thursday. The firm currently has a “buy” rating on the stock. Investec’s price objective indicates a potential upside of 18.88% from the stock’s previous close.
MRO has been the subject of a number of other recent research reports. Analysts at RBC Capital reiterated an “outperform” rating on shares of Melrose Industries Plc in a research note on Tuesday. They now have a GBX 330 ($5.46) price target on the stock. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of GBX 326.80 ($5.41).
Melrose Industries Plc (LON:MRO) traded down 0.61% on Thursday, hitting GBX 277.00. The stock had a trading volume of 4,477,240 shares. Melrose Industries Plc has a one year low of GBX 246.70 and a one year high of GBX 382.20. The stock has a 50-day moving average of GBX 267.1 and a 200-day moving average of GBX 283.4. The company’s market cap is £2.969 billion.
The company also recently declared a dividend, which is scheduled for Thursday, October 16th. Shareholders of record on Wednesday, September 17th will be given a dividend of GBX 2.80 ($0.05) per share. This represents a yield of 1.01%. The ex-dividend date of this dividend is Wednesday, September 17th.
Melrose PLC operates through three divisions: Energy, Lifting and Other Industrial. The Energy segment incorporates the Turbogenerators (LON:MRO) and Marelli business units, specialist suppliers of energy industrial products to the worldwide market.
Receive News & Ratings for Melrose Industries Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Melrose Industries Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.